Android app Apple app link

GoodRx Holdings, Inc. (GDRX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.2
Day's range
$2.37

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
05/08/2026 Goldman Sachs Eric Sheridan $3.50 $2.84   23.24%
02/26/2026 Leerink Partners Michael Cherny $3.00 $2.02   48.21%
01/22/2026 Jefferies Glen Santangelo $2.75 $2.58   6.59%
08/11/2025 Deutsche Bank George Hill $6.00 $3.47   72.91%
06/10/2024 Morgan Stanley Craig Hettenbach $9.50 $8.55   11.11%
05/22/2024 RBC Capital Mark Mahaney $10.00 $7.20   38.89%
05/16/2024 Barclays Stephanie Davis $9.00 $8.06   11.66%
05/16/2024 Raymond James Aaron Kessler $10.00 $7.27   37.55%
04/10/2024 BOCOM International Holdings Company Scott Schoenhaus $9.00 $6.92   30.06%
04/09/2024 KeyBanc Scott Schoenhaus $9.00 $6.74   33.53%
03/25/2024 Wells Fargo Stan Berenshteyn $10.00 $7.23   38.39%
11/13/2023 Goldman Sachs Eric Sheridan $3.00 $4.73   -36.58%
02/28/2022 J.P. Morgan Doug Anmuth $20.00 $16.74   19.47%
02/28/2022 Cowen & Co. Charles Rhyee $22.00 $16.74   31.42%
02/28/2022 Goldman Sachs Eric Sheridan $30.00 $16.74   79.21%
02/28/2022 Deutsche Bank George Hill $20.00 $16.74   19.47%
02/28/2022 Bank of America Securities Justin Post $28.00 $16.74   67.26%
12/20/2021 Stephens Scott Schoenhaus $45.00 $35.83   25.59%
05/13/2021 Citigroup Nicholas Jones CFA $53.00 $30.97   71.13%

GoodRx Holdings Inc FAQ's

GoodRx Holdings Inc has been rated by research analysts at Barclays, UBS, Goldman Sachs, Leerink Partners, Jefferies, Morgan Stanley in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.